![](/img/cover-not-exists.png)
Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer
Chris Twelves, Javier Cortes, Linda T. Vahdat, Jantien Wanders, Corina Akerele, Peter A. KaufmanVolume:
10
Year:
2010
Language:
english
Pages:
4
DOI:
10.3816/cbc.2010.n.023
File:
PDF, 200 KB
english, 2010